Skip to main content

ADVERTISEMENT

Jolynn Tumolo

News
11/09/2023
Jolynn Tumolo
Safecor Health is recalling 166,022 bottles of strong iodine solution because of Current Good Manufacturing Practice deviations. The November 8, 2023, US Food and Drug Administration (FDA) Enforcement Report cites the absence of compendial...
Safecor Health is recalling 166,022 bottles of strong iodine solution because of Current Good Manufacturing Practice deviations. The November 8, 2023, US Food and Drug Administration (FDA) Enforcement Report cites the absence of compendial...
Safecor Health is recalling...
11/09/2023
Pharmacy Learning Network
News
11/08/2023
Jolynn Tumolo
The recall affects Gynazole-1 (butoconazole nitrate) vaginal cream, 2%, 1 prefilled applicator per carton (NDC 45802-396-01), from lot 164185 (Exp. 4/24). The product was manufactured by Padagis, Yeruham, Israel, and distributed by Padagis,...
The recall affects Gynazole-1 (butoconazole nitrate) vaginal cream, 2%, 1 prefilled applicator per carton (NDC 45802-396-01), from lot 164185 (Exp. 4/24). The product was manufactured by Padagis, Yeruham, Israel, and distributed by Padagis,...
The recall affects Gynazole-1...
11/08/2023
Pharmacy Learning Network
A little girl sleeps with her mouth hanging open
News
11/08/2023
Jolynn Tumolo
Hitting the snooze button for 30 minutes in the morning slightly improved or did not affect cognitive performance upon waking in habitual snoozers, according to research published in the Journal of Sleep Research.
Hitting the snooze button for 30 minutes in the morning slightly improved or did not affect cognitive performance upon waking in habitual snoozers, according to research published in the Journal of Sleep Research.
Hitting the snooze button for 30...
11/08/2023
Neurology
News
11/07/2023
Jolynn Tumolo
Dazdotuftide, a novel multi-target drug, offers promising potential for the treatment of diabetic retinopathy (DR), diabetic macular edema (DME), and age-related macular degeneration (AMD).
Dazdotuftide, a novel multi-target drug, offers promising potential for the treatment of diabetic retinopathy (DR), diabetic macular edema (DME), and age-related macular degeneration (AMD).
Dazdotuftide, a novel...
11/07/2023
First Report Managed Care
News
11/06/2023
Jolynn Tumolo
Researchers suggest that vagus nerve stimulation (VNS) may decrease the frequency of seizures, potentially enhancing patient well-being and reducing health care expenses for Medicare. However, they acknowledge the need for additional data to...
Researchers suggest that vagus nerve stimulation (VNS) may decrease the frequency of seizures, potentially enhancing patient well-being and reducing health care expenses for Medicare. However, they acknowledge the need for additional data to...
Researchers suggest that vagus...
11/06/2023
Pharmacy Learning Network
News
11/06/2023
Jolynn Tumolo
While the terms nonradiographic axial spondyloarthritis (NrxSpA) and radiographic axial spondyloarthritis (R-axSpA) may sometimes be helpful for stratifying patients with axial spondyloarthritis (axSpA) in clinical studies, the terms are less...
While the terms nonradiographic axial spondyloarthritis (NrxSpA) and radiographic axial spondyloarthritis (R-axSpA) may sometimes be helpful for stratifying patients with axial spondyloarthritis (axSpA) in clinical studies, the terms are less...
While the terms nonradiographic...
11/06/2023
First Report Managed Care
stock brain image
News
11/06/2023
Jolynn Tumolo
The efficacy of blonanserin, a second-generation antipsychotic approved for the treatment of schizophrenia in Japan, South Korea, and China, is similar to that of risperidone, although the medications differ in terms of adverse events.
The efficacy of blonanserin, a second-generation antipsychotic approved for the treatment of schizophrenia in Japan, South Korea, and China, is similar to that of risperidone, although the medications differ in terms of adverse events.
The efficacy of blonanserin, a...
11/06/2023
Psych Congress Network
News
11/03/2023
Jolynn Tumolo
Biomic Sciences, which does business as ION Intelligence of Nature, recalls Restore Sinus Spray due to potential microbial contamination. The recall was published in the November 1, 2023, US Food and Drug Administration (FDA) Enforcement...
Biomic Sciences, which does business as ION Intelligence of Nature, recalls Restore Sinus Spray due to potential microbial contamination. The recall was published in the November 1, 2023, US Food and Drug Administration (FDA) Enforcement...
Biomic Sciences, which does...
11/03/2023
Pharmacy Learning Network
News
11/03/2023
Jolynn Tumolo
The Janus kinase (JAK) inhibitor upadacitinib offers a similar long-term safety profile across rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and atopic dermatitis (AD) despite some variations in adverse...
The Janus kinase (JAK) inhibitor upadacitinib offers a similar long-term safety profile across rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and atopic dermatitis (AD) despite some variations in adverse...
The Janus kinase (JAK) inhibitor...
11/03/2023
First Report Managed Care
News
11/03/2023
Jolynn Tumolo
Health systems are partnering with the American Thoracic Society to collect baseline immunization data and test strategies for improving immunization rates. The plan aims to identify strategies that work in specific populations and across...
Health systems are partnering with the American Thoracic Society to collect baseline immunization data and test strategies for improving immunization rates. The plan aims to identify strategies that work in specific populations and across...
Health systems are partnering...
11/03/2023
Pharmacy Learning Network